文献速递慢性肾脏病遗传性与小管间质肾病

组蛋白H3 K79甲基转移酶Dot1l缺失通过HDAC2上调内皮素1促进肾纤维化

Loss of Histone H3 K79 Methyltransferase Dot1l Facilitates Kidney Fibrosis by Upregulating Endothelin 1 through Histone Deacetylase 2.
PubMed 文献 · J Am Soc Nephrol · 2019-12-16

该研究在小鼠中探讨Dot1l缺失是否通过调控Edn1促进肾纤维化。在链脲佐菌素诱导糖尿病、正常衰老及单侧输尿管梗阻三种条件下,连接小管/集合管特异性Dot1l敲除小鼠均出现更明显的肾纤维化和肾功能异常,而同时敲除Edn1可改善该表型。机制上,Dot1a与HDAC2相互作用,通过调节Edn1启动子H3 K79二甲基化和H3乙酰化调控Edn1转录。

要点

  • Dot1l缺失是肾纤维化的遗传和表观遗传风险因素
  • Dot1l缺失通过上调内皮素1促进肾纤维化
  • 内皮素1是肾纤维化的治疗靶点

核心结论

  • Dot1l是肾纤维化的遗传和表观遗传修饰因子。
  • Dot1a与HDAC2通过调节Edn1启动子组蛋白修饰调控Edn1转录。
  • 内皮素1是肾纤维化的治疗靶点。

研究设计与样本

  • 研究纳入四组小鼠:野生型、连接小管/集合管特异性Dot1l条件敲除(Dot1lAC)、Dot1l与Edn1双敲除(DEAC)、Edn1连接小管/集合管特异性条件敲除(Edn1AC)。
  • 在链脲佐菌素诱导糖尿病、正常衰老及单侧输尿管梗阻三种实验条件下观察。
  • 采用共定位、GST pull-down、免疫共沉淀、酵母双杂交、凝胶迁移和染色质免疫沉淀等实验确认Dot1a与HDAC2相互作用及其对Edn1转录的调控。

主要发现

  • 在三种实验条件下,Dot1lAC小鼠均较野生型出现更明显的肾纤维化和肾功能异常。
  • DEAC双敲除小鼠中Dot1lAC表型得到改善。
  • Dot1a与HDAC2的相互作用阻止Dot1a-HDAC2复合物与DNA结合,构成调控Edn1转录的平衡机制。

临床怎么用

  • Dot1l缺失可作为肾纤维化遗传和表观遗传风险评估的潜在标志。
  • 内皮素1通路是肾纤维化的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The progression rate of CKD varies substantially among patients. The genetic and epigenetic contributions that modify how individual patients respond to kidney injury are largely unknown. Emerging evidence has suggested that histone H3 K79 methyltransferase Dot1l has an antifibrotic effect by repressing Edn1, which encodes endothelin 1 in the connecting tubule/collecting duct. METHODS: To determine if deletion of the Dot1l gene is a genetic and epigenetic risk factor through regulating Edn1, we studied four groups of mice: wild-type mice, connecting tubule/collecting duct-specific Dot1l conditional knockout mice (Dot1lAC ), Dot1l and Edn1 double-knockout mice (DEAC ), and Edn1 connecting tubule/collecting duct-specific conditional knockout mice (Edn1AC ), under three experimental conditions (streptozotocin-induced diabetes, during normal aging, and after unilateral ureteral obstruction). We used several approaches (colocalization, glutathione S-transferase pulldown, coimmunoprecipitation, yeast two-hybrid, gel shift, and chromatin immunoprecipitation assays) to identify and confirm interaction of Dot1a (the major Dot1l splicing variant in the mouse kidney) with histone deacetylase 2 (HDAC2), as well as the function of the Dot1a-HDAC2 complex in regulating Edn1 transcription. RESULTS: In each case, Dot1lAC mice developed more pronounced kidney fibrosis and kidney malfunction compared with wild-type mice. These Dot1lAC phenotypes were ameliorated in the double-knockout DEAC mice. The interaction between Dot1a and HDAC2 prevents the Dot1a-HDAC2 complex from association with DNA, providing a counterbalancing mechanism governing Edn1 transcription by modulating H3 K79 dimethylation and H3 acetylation at the Edn1 promoter. CONCLUSIONS: Our study confirms Dot1l to be a genetic and epigenetic modifier of kidney fibrosis, reveals a new mechanism regulating Edn1 transcription by Dot1a and HDAC2, and reinforces endothelin 1 as a therapeutic target of kidney fibrosis.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Zhang L, Chen L, Gao C, et al. Loss of Histone H3 K79 Methyltransferase Dot1l Facilitates Kidney Fibrosis by Upregulating Endothelin 1 through Histone Deacetylase 2. J Am Soc Nephrol. 2019. PMID: 31843983. doi:10.1681/ASN.2019070739

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。